Skip to main content
CHRS
NASDAQ Life Sciences

Coherus Hires Oppenheimer to Sell Legacy Biosimilar Assets

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.245
Mkt Cap
$192.354M
52W Low
$1.09
52W High
$2.616
52W Position info
14% above low
Off High info
52% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

CHRS is trading near its 52-week low of $1.09 (14% above the low).

Summary

Coherus has formally begun marketing its remaining biosimilar assets and retained Oppenheimer & Co. as financial adviser. This follows the August 17 CVR dividend tied to future monetization of those assets. The stock is down 4% at $1.25, reflecting uncertainty about the sale proceeds. The company's Q2 cash of $105.3M was already tight, and this sale is a key step to unlock value for CVR holders. Watch for any announced buyer or terms, which will directly determine the CVR payout.

At the time of this announcement, CHRS was trading at $1.25 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $192.4M. The 52-week trading range was $1.09 to $2.62. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

CHRS - Latest Insights

CHRS
Nov 09, 2026, 4:59 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.8008
Real-time Price: $0.400 info
Change: -$0.4008 (-50%) info
Market Cap: $59.822M info
CHRS
Nov 09, 2026, 4:20 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.7976
Real-time Price: $0.400 info
Change: -$0.3976 (-50%) info
Market Cap: $59.822M info
CHRS
Nov 09, 2026, 4:07 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.770
Real-time Price: $0.400 info
Change: -$0.370 (-48%) info
Market Cap: $59.822M info
CHRS
Oct 29, 2026, 8:10 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.05
Real-time Price: $0.400 info
Change: -$0.650 (-62%) info
Market Cap: $59.822M info
CHRS
Aug 17, 2026, 5:36 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $1.23
Real-time Price: $0.400 info
Change: -$0.830 (-67%) info
Market Cap: $59.822M info